Growth Metrics

LifeMD (LFMD) Current Deferred Revenue (2018 - 2025)

LifeMD's Current Deferred Revenue history spans 8 years, with the latest figure at $10.8 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue fell 36.84% year-over-year to $10.8 million; the TTM value through Dec 2025 reached $10.8 million, down 36.84%, while the annual FY2025 figure was $10.8 million, 36.84% down from the prior year.
  • Current Deferred Revenue reached $10.8 million in Q4 2025 per LFMD's latest filing, down from $14.4 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $20.6 million in Q3 2024 to a low of $1.3 million in Q1 2021.
  • Average Current Deferred Revenue over 5 years is $8.4 million, with a median of $6.1 million recorded in 2023.
  • Peak YoY movement for Current Deferred Revenue: soared 355.08% in 2021, then plummeted 36.84% in 2025.
  • A 5-year view of Current Deferred Revenue shows it stood at $1.5 million in 2021, then soared by 269.86% to $5.5 million in 2022, then soared by 31.08% to $7.3 million in 2023, then soared by 135.16% to $17.1 million in 2024, then tumbled by 36.84% to $10.8 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Current Deferred Revenue are $10.8 million (Q4 2025), $14.4 million (Q3 2025), and $16.9 million (Q2 2025).